Afloqualone (CAS 56287-74-2) Suppliers and Product Information

Afloqualone is a synthetic quinazoline-based compound with muscle relaxant properties. It has been studied for its effects on various conditions, including epilepsy, depression, anxiety, and cancer. The compound has demonstrated anticonvulsant, anxiolytic, and anti-inflammatory properties in studies. It is believed to modulate the activity of the GABA-A receptor, which plays a crucial role in regulating neural excitability.

Afloqualone has shown potential in reducing the severity of depression and anxiety in animal models. It also exhibits inhibitory effects on cancer cell growth and has been observed to reduce the production of pro-inflammatory cytokines, supporting its anti-inflammatory properties.

Frequently Asked Questions about Afloqualone

Q: What is the primary use of Afloqualone?

A: Afloqualone is primarily used as a centrally acting muscle relaxant. It is useful in the management of various spastic conditions, including cerebral palsy, cervical spondylosis, and multiple sclerosis.

Q: How does Afloqualone work?

A: Afloqualone is believed to work by modulating the activity of the GABA-A receptor, which plays a crucial role in regulating neural excitability. It also demonstrates anti-inflammatory properties by reducing the production of pro-inflammatory cytokines.

Q: What are some potential applications of Afloqualone beyond muscle relaxation?

A: Studies have shown that Afloqualone may have potential applications in treating epilepsy, depression, anxiety, and cancer. It has demonstrated anticonvulsant, anxiolytic, and anti-inflammatory properties, as well as inhibitory effects on cancer cell growth.

Q: How should Afloqualone be stored?

A: Afloqualone should be stored at room temperature.

Q: What is the typical purity of commercially available Afloqualone?

A: The purity of commercially available Afloqualone is typically ≥98.0%, as per specifications provided by suppliers.